clinical trial · NCT05254457
Long-Term Safety, Efficacy, and Durability of EN3835 in the Treatment and Retreatment of Plantar Fibromatosis
Plantar FibromatosisEN3835
brief summary
Assess the long-term safety and efficacy of EN3835 in participants who have participated in a parent placebo-controlled study of EN3835 (EN3835-222, NCT05152173) and assess the efficacy and safety of EN3835 in the treatment and retreatment of plantar fibromatosis.
started
Feb 14, 2022
primary completion
Mar 21, 2024
completion
Mar 21, 2024
last updated
Mar 21, 2025
official title
A Multi-Center, Open-Label, Extension Study to Evaluate the Long-Term Safety, Efficacy, and Durability of EN3835 in the Treatment and Retreatment of Plantar Fibromatosis
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol